Report Detail
Global (United States, European Union and China) Antipsychotic Drugs Market Research Report 2019-2025
- RnM3687038 |
- 21 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder.
During 2016, the second-generation antipsychotic drugs segment dominated the antipsychotic drugs market with the highest market shares. These drugs are preferred over first-generation antipsychotic drugs because they involve lesser side effects and are highly efficient in the treatment of various mental disorders. The adoption of these drugs is high because they reduce EPSE, controls symptoms, and maintains the normal levels of prolactin. This segment yields a high prescription value that in turn, will drive growth in the segment during the forecasted period.
In 2019, the market size of Antipsychotic Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Antipsychotic Drugs.
This report studies the global market size of Antipsychotic Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Antipsychotic Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
AstraZeneca
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
Actavis Generics
Alkermes
Bristol-Myers Squibb
...
Market Segment by Product Type
First Antipsychotic Drugs
Second Antipsychotic Drugs
Third Antipsychotic Drugs
Market Segment by Application
Schizophrenia
Bipolar Disorder
Unipolar Depression
Dementia
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Antipsychotic Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Antipsychotic Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Antipsychotic Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Antipsychotic Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 First Antipsychotic Drugs
- 1.3.3 Second Antipsychotic Drugs
- 1.3.4 Third Antipsychotic Drugs
- 1.4 Market Segment by Application
- 1.4.1 Global Antipsychotic Drugs Market Share by Application (2019-2025)
- 1.4.2 Schizophrenia
- 1.4.3 Bipolar Disorder
- 1.4.4 Unipolar Depression
- 1.4.5 Dementia
- 1.4.6 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Antipsychotic Drugs Market Size
- 2.1.1 Global Antipsychotic Drugs Revenue 2014-2025
- 2.1.2 Global Antipsychotic Drugs Sales 2014-2025
- 2.2 Antipsychotic Drugs Growth Rate by Regions
- 2.2.1 Global Antipsychotic Drugs Sales by Regions 2014-2019
- 2.2.2 Global Antipsychotic Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Antipsychotic Drugs Sales by Manufacturers
- 3.1.1 Antipsychotic Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Antipsychotic Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Antipsychotic Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Antipsychotic Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Antipsychotic Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Antipsychotic Drugs Price by Manufacturers
- 3.4 Key Manufacturers Antipsychotic Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Antipsychotic Drugs Market
- 3.6 Key Manufacturers Antipsychotic Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 First Antipsychotic Drugs Sales and Revenue (2014-2019)
- 4.1.2 Second Antipsychotic Drugs Sales and Revenue (2014-2019)
- 4.1.3 Third Antipsychotic Drugs Sales and Revenue (2014-2019)
- 4.2 Global Antipsychotic Drugs Sales Market Share by Type
- 4.3 Global Antipsychotic Drugs Revenue Market Share by Type
- 4.4 Antipsychotic Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Antipsychotic Drugs Sales by Application
6 United States
- 6.1 United States Antipsychotic Drugs Breakdown Data by Company
- 6.2 United States Antipsychotic Drugs Breakdown Data by Type
- 6.3 United States Antipsychotic Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Antipsychotic Drugs Breakdown Data by Company
- 7.2 European Union Antipsychotic Drugs Breakdown Data by Type
- 7.3 European Union Antipsychotic Drugs Breakdown Data by Application
8 China
- 8.1 China Antipsychotic Drugs Breakdown Data by Company
- 8.2 China Antipsychotic Drugs Breakdown Data by Type
- 8.3 China Antipsychotic Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Antipsychotic Drugs Breakdown Data by Company
- 9.2 Rest of World Antipsychotic Drugs Breakdown Data by Type
- 9.3 Rest of World Antipsychotic Drugs Breakdown Data by Application
- 9.4 Rest of World Antipsychotic Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Antipsychotic Drugs Sales by Countries
- 9.4.2 Rest of World Antipsychotic Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 AstraZeneca
- 10.1.1 AstraZeneca Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.1.4 Antipsychotic Drugs Product Introduction
- 10.1.5 AstraZeneca Recent Development
- 10.2 Eli Lilly
- 10.2.1 Eli Lilly Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.2.4 Antipsychotic Drugs Product Introduction
- 10.2.5 Eli Lilly Recent Development
- 10.3 GlaxoSmithKline
- 10.3.1 GlaxoSmithKline Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.3.4 Antipsychotic Drugs Product Introduction
- 10.3.5 GlaxoSmithKline Recent Development
- 10.4 Johnson & Johnson
- 10.4.1 Johnson & Johnson Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.4.4 Antipsychotic Drugs Product Introduction
- 10.4.5 Johnson & Johnson Recent Development
- 10.5 Actavis Generics
- 10.5.1 Actavis Generics Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.5.4 Antipsychotic Drugs Product Introduction
- 10.5.5 Actavis Generics Recent Development
- 10.6 Alkermes
- 10.6.1 Alkermes Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.6.4 Antipsychotic Drugs Product Introduction
- 10.6.5 Alkermes Recent Development
- 10.7 Bristol-Myers Squibb
- 10.7.1 Bristol-Myers Squibb Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Antipsychotic Drugs
- 10.7.4 Antipsychotic Drugs Product Introduction
- 10.7.5 Bristol-Myers Squibb Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Antipsychotic Drugs Sales Channels
- 11.2.2 Antipsychotic Drugs Distributors
- 11.3 Antipsychotic Drugs Customers
12 Market Forecast
- 12.1 Global Antipsychotic Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Antipsychotic Drugs Sales Forecast by Type
- 12.3 Global Antipsychotic Drugs Sales Forecast by Application
- 12.4 Antipsychotic Drugs Forecast by Regions
- 12.4.1 Global Antipsychotic Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Antipsychotic Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Antipsychotic Drugs. Industry analysis & Market Report on Antipsychotic Drugs is a syndicated market report, published as Global (United States, European Union and China) Antipsychotic Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Antipsychotic Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
